Ligand validation:3CSI

LZ6: L-gamma-glutamyl-S-(2-{[4-(3-carboxypropyl)phenyl](2-chloroethyl)amino}ethyl)-L-cysteinylglycine

LZ6 is a Ligand Of Interest in 3CSI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CSI_LZ6_D_214	76%	51%	0.116	0.951	0.69	1.18	-	3	0	0	100%	0.7
3CSI_LZ6_A_212	73%	54%	0.115	0.941	0.78	1.01	-	2	5	0	100%	0.7
3CSI_LZ6_C_211	70%	52%	0.123	0.94	0.68	1.17	-	4	8	0	100%	0.7
3CSI_LZ6_B_216	66%	55%	0.122	0.928	0.8	0.94	1	1	2	0	100%	0.7
3CSH_LZ6_B_214	76%	54%	0.112	0.947	0.74	1.03	-	2	4	0	100%	0.8
4HJ2_LZ6_A_301	24%	52%	0.216	0.844	0.93	0.93	1	1	13	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.